424 related articles for article (PubMed ID: 10616837)
1. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
Riser BL; Cortes P
Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
[TBL] [Abstract][Full Text] [Related]
3. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
[TBL] [Abstract][Full Text] [Related]
4. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
7. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
8. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
Murphy M; Godson C; Cannon S; Kato S; Mackenzie HS; Martin F; Brady HR
J Biol Chem; 1999 Feb; 274(9):5830-4. PubMed ID: 10026205
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
[TBL] [Abstract][Full Text] [Related]
10. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
12. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
[TBL] [Abstract][Full Text] [Related]
13. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.
Chen MM; Lam A; Abraham JA; Schreiner GF; Joly AH
J Mol Cell Cardiol; 2000 Oct; 32(10):1805-19. PubMed ID: 11013125
[TBL] [Abstract][Full Text] [Related]
14. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
15. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.
Weston BS; Wahab NA; Mason RM
J Am Soc Nephrol; 2003 Mar; 14(3):601-10. PubMed ID: 12595495
[TBL] [Abstract][Full Text] [Related]
16. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis.
Yokoi H; Mukoyama M; Sugawara A; Mori K; Nagae T; Makino H; Suganami T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
Am J Physiol Renal Physiol; 2002 May; 282(5):F933-42. PubMed ID: 11934704
[TBL] [Abstract][Full Text] [Related]
17. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
[TBL] [Abstract][Full Text] [Related]
19. Static pressure regulates connective tissue growth factor expression in human mesangial cells.
Hishikawa K; Oemar BS; Nakaki T
J Biol Chem; 2001 May; 276(20):16797-803. PubMed ID: 11278731
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.
Zhou G; Li C; Cai L
Am J Pathol; 2004 Dec; 165(6):2033-43. PubMed ID: 15579446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]